agilon health(AGL)

Search documents
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
ZACKS· 2024-08-06 22:21
Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this senior-focused health care company would post a loss of $0.02 per share when it actually produced earnings of $0.01, delivering a surprise of 150%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Agilon, which belo ...
agilon health(AGL) - 2024 Q2 - Quarterly Report
2024-08-06 20:08
FORM 10-Q _______________________________________________________ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ Delaware 37-1915147 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT T ...
agilon health(AGL) - 2024 Q2 - Quarterly Results
2024-08-06 20:04
Exhibit 99.1 agilon health Reports Second Quarter 2024 Results Revenue increased 39% to $1.5 billion, Medicare Advantage membership increased 38% to 513,000, and total members on the agilon platform grew 40% to 645,000 Executing targeted action plan and prioritizing profitability First half results reflect retroactive membership adjustments to January 1, 2024 related to agilon's termination of select contracts Maintains 2024 Medical Margin and Adjusted EBITDA Guidance AUSTIN, T.X., August 6, 2024 – agilon h ...
The Portnoy Law Firm Announces Investigation of agilon health, inc. (NYSE: AGL)
GlobeNewswire News Room· 2024-06-10 19:57
Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, June 10, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm is investigating potential claims against the board of directors of agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Agilon Health is a company focused on health care for seniors by partnering with primary care physicians. They provide support to help physicians, while also managing the administrative and financial aspects of care. If you ...
Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP agilon health, inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (AGL)
prnewswire.com· 2024-05-19 23:30
RADNOR, Pa., May 19, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. (NYSE: AGL) ("agilon" or the "Company"). This action, captioned Hope v. agilon health, inc., et al., Case No. 1:24-cv-00305, was filed in the United States District Court for the Western District of Texas and expanded the class period which was pled in a first-filed case in that same Court. After the Hope ...
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit
prnewswire.com· 2024-05-16 17:45
LOS ANGELES, May 16, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL).Class Period: April 15, 2021 – February 27, 2024Lead Plaintiff Deadline: May 20, 2024If you wish to serve as lead plaintiff of the agilon lawsuit, you can submit your contact information at https://www.glancylaw.com/cases/agilon-health-inc/. You can ...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGL
prnewswire.com· 2024-05-16 16:20
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Agilon and certain of its officers and/o ...
agilon health(AGL) - 2024 Q1 - Earnings Call Transcript
2024-05-09 00:33
agilon health, inc. (NYSE:AGL) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Ryan Daniels - William Blair Dean Rosales - Wolfe Research Jailendra Singh - Truist Adam Ron - Bank of America Sean Dodge - RBC Capital Markets Jack Slevin - Jefferies George Hill - Deutsche Bank Sameer Patel - Evercore ISI Operator Hello, everyone, and welcome to the agilon health First Quarter 2024 Earnings Conf ...
Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research· 2024-05-07 23:31
For the quarter ended March 2024, Agilon Health (AGL) reported revenue of $1.6 billion, up 41.2% over the same period last year. EPS came in at $0.01, compared to $0.04 in the year-ago quarter.The reported revenue represents a surprise of -0.85% over the Zacks Consensus Estimate of $1.62 billion. With the consensus EPS estimate being -$0.02, the EPS surprise was +150.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine the ...
agilon health(AGL) - 2024 Q1 - Quarterly Report
2024-05-07 20:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0 ...